Proatherogenic adipocytokines levels in metabolic syndrome

Romanian Journal of Morphology and Embryology

Volumn 55, Issue 1, 2014, Pages 29-33

  Bǎlǎşoiu, Maria ^a,b   Bǎlǎşoiu, Andrei Theodor ^b   Stepan, Alex Emilian ^a,b   Dinescu, Sorin Nicolae ^a,c   Avrǎmescu, Carmen Silvia ^a,b   Dumitrescu, Daniela ^a,b   Cernea, Daniela ^a,b   Alexandru, Dragoş ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b EMERGENCY COUNTY HOSPITAL   (Romania)

^c Dr tefan Odobleja Emergency Military Hospital   (Romania)

Author keywords

Adipocytokine; Leptin; Metabolic syndrome

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; COMPLICATION; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED;

ADIPOKINES; ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898621072     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ***, The IDF Consensus Worldwide Definition of the Metabolic Syndrome, International Diabetes Federation (IDF), IDF Communications, Brussels, Belgium, 2006, http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf.
2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute, Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 2005, 112(17):2735-2752.
3. ***, World Health Report 2002 - Reducing risk, promoting healthy life. Mentioned in: Zipes DP, Libby P, Bonow RO, Braunwald E (eds), Braunwald's heart disease: a textbook of cardiovascular medicine, 7th edition, Elsevier Saunders, 2005, 1-19.
4. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB, Overweight and obesity as determinants of cardiovascular risk: the Framingham experience, Arch Intern Med, 2002, 162(16):1867-1872.
5. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Abdominal adiposity and coronary heart disease in women, JAMA, 1998, 280(21): 1843-1848.
6. ***, Diabetes and obesity: time to act, International Association for the Study of Obesity, 2007.
7. Ross R, Atherosclerosis - an inflammatory disease, N Engl J Med, 1999, 340(2):115-126.
8. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group, The metabolic syndrome - a new worldwide definition, Lancet, 2005, 366(9491):1059-1062.
9. Berg AH, Scherer PE, Adipose tissue, inflammation, and cardiovascular disease, Circ Res, 2005, 96(9):939-949.
10. Poiac M, Brega D, Popa I, Sindromul metabolic la copil şi adolescent - factor de risc cardiovascular la adult (The metabolic syndrome in children and adolescents - risk factor for adult cardiovascular diseases), Revista Românǎ de Pediatrie, 2009, LVIII(3):234-239.
11. Pischon T, Rimm EB, Adiponectin and risk of acute coronary syndromes: defining the obesity phenotype, Eur Heart J, 2007, 28(3):274-275.
12. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S, Adipokines: molecular links between obesity and atherosclerosis, Am J Physiol Heart Circ Physiol, 2005, 288(5):H2031-H2041.
13. Popa A, Adam F, Câltea C, Câltea A, Buzatu I, Chiurcu CI, Sinescu C, Aspecte ale interrelaţiei obezitǎţii cu apariţia şi evoluţia afecţiunilor vasculare, Medicina Modernǎ, 2009, XVI(11):130-145.
14. Konstantinides S, Schafer K, Loskutoff DJ, The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity, Ann N Y Acad Sci, 2001, 947: 134-141; discussion 141-142.
15. Cooke JP, Oka RK, Does leptin cause vascular disease? Circulation, 2002, 106(15):1904-1905.
16. Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayama K, Leptin causes nitric-oxide independent coronary artery vasodilation in humans, Hypertens Res, 2003, 26(2): 147-152.
17. Friedman JM, Effects of leptin treatment on weight loss, ClinicalTrials.gov Identifier: NCT00050791; Rockefeller University, Last updated: October 18, 2010.
18. Erdmann J, Lippl F, Wagenpfeil S, Schusdziarra V, Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes, Diabetes, 2005, 54(5): 1371-1378.